Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid 5-dimethoxyphenyl)quinazolin-2-yl)amino)-3-methylphenyl)acrylamide

5-dimethoxyphenyl)quinazolin-2-yl)amino)-3-methylphenyl)acrylamide

Ginkgolide B diminishes P-selectin

223(1):57-64

is a Hepatic Differentiation Inducer which is able to induce the differentiation of rat MSCs (rMSCs) toward hepatocyte-like cells in vitro

(and inhibition) of androgen receptor

Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid 5-dimethoxyphenyl)quinazolin-2-yl)amino)-3-methylphenyl)acrylamideLinifanib, CAS No. 796967 16 3, also known as ABT 869, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine threonine kinases. This agent does not have a